thymine has been researched along with Cancer of Prostate in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Studies using the PC-3 human prostate cancer cell line demonstrate that X-ray excitation of these psoralen-functionalized Y(2)O(3) nanoscintillators yields concentration-dependent reductions in cell number when compared to control cultures containing psoralen-free Y(2)O(3) nanoscintillators." | 1.37 | Activity of psoralen-functionalized nanoscintillators against cancer cells upon X-ray excitation. ( Gregas, MK; Lauly, B; Scaffidi, JP; Vo-Dinh, T; Zhang, Y, 2011) |
| "The formation or progression of prostate cancer is presumed to be associated with a polymorphism of the vascular endothelial growth factor (VEGF) gene." | 1.32 | Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. ( Chen, HY; Chen, WC; Lin, CC; Tsai, FJ; Wu, HC, 2003) |
| "Established prostate cancer-derived cell lines LnCAP, DU-145, and PC-3 demonstrated NQO1 wild-type genotype." | 1.30 | 609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. ( Borkowsi, M; Hillenbrand, M; Schuff-Werner, P; Seiter, H; Steiner, M, 1999) |
| "By contrast, androgen-independent human prostate cancer cells do not activate this apoptotic pathway in response to androgen ablation." | 1.29 | Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death. ( Bains, AK; Jacobs, SC; Kyprianou, N, 1994) |
| "Human prostate cancer cells (LNCaP) were grown under different conditions and analyzed for differential expression of mRNA." | 1.29 | Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells. ( Kirschenbaum, A; Levine, AC; Liu, BC; Miniati, DN; Robbins, SE; Shu, WP, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roy, J | 1 |
| Kaake, M | 1 |
| Srinivasarao, M | 1 |
| Low, PS | 1 |
| Scaffidi, JP | 1 |
| Gregas, MK | 1 |
| Lauly, B | 1 |
| Zhang, Y | 1 |
| Vo-Dinh, T | 1 |
| Lin, CC | 1 |
| Wu, HC | 1 |
| Tsai, FJ | 1 |
| Chen, HY | 1 |
| Chen, WC | 1 |
| Kyprianou, N | 2 |
| Bains, AK | 1 |
| Jacobs, SC | 1 |
| Robbins, SE | 1 |
| Shu, WP | 1 |
| Kirschenbaum, A | 1 |
| Levine, AC | 1 |
| Miniati, DN | 1 |
| Liu, BC | 1 |
| Tsurusaki, T | 1 |
| Koji, T | 1 |
| Sakai, H | 1 |
| Kanetake, H | 1 |
| Saito, Y | 1 |
| Steiner, M | 1 |
| Hillenbrand, M | 1 |
| Borkowsi, M | 1 |
| Seiter, H | 1 |
| Schuff-Werner, P | 1 |
| Isaacs, JT | 1 |
8 other studies available for thymine and Cancer of Prostate
| Article | Year |
|---|---|
Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Drug Delivery Systems; Endometrial Neoplasms; Fema | 2018 |
Activity of psoralen-functionalized nanoscintillators against cancer cells upon X-ray excitation.
Topics: Adenine; Apoptosis; Cell Line, Tumor; DNA; Drug Screening Assays, Antitumor; Ficusin; Humans; Male; | 2011 |
Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Cytosine; Endothelial Growth Factors; Genetic Markers; H | 2003 |
Induction of apoptosis in androgen-independent human prostate cancer cells undergoing thymineless death.
Topics: Apoptosis; Blotting, Northern; Cell Survival; DNA, Neoplasm; Humans; Male; Prostatic Neoplasms; RNA, | 1994 |
Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
Topics: Adenine; Androgens; Animals; Base Sequence; Binding Sites; Bone and Bones; Cell Division; Dihydrotes | 1996 |
Expression profile of prostate-specific antigen messenger RNA assessed by in situ hybridization is a novel prognostic marker for patients with untreated prostate cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Dimerization; DNA, Neoplasm; Female; Humans; Immunohisto | 1998 |
609 C --> T polymorphism in NAD(P)H:quinone oxidoreductase gene in patients with prostatic adenocarcinoma or benign prostatic hyperplasia.
Topics: Adenocarcinoma; Alleles; Cytosine; Female; Genes, Neoplasm; Genotype; Humans; Male; NAD(P)H Dehydrog | 1999 |
"Thymineless" death in androgen-independent prostatic cancer cells.
Topics: Animals; Blotting, Northern; Cell Line; Cell Survival; DNA, Neoplasm; Drug Screening Assays, Antitum | 1989 |